377 related articles for article (PubMed ID: 19675329)
1. Micrometastases or isolated tumor cells and the outcome of breast cancer.
de Boer M; van Deurzen CH; van Dijck JA; Borm GF; van Diest PJ; Adang EM; Nortier JW; Rutgers EJ; Seynaeve C; Menke-Pluymers MB; Bult P; Tjan-Heijnen VC
N Engl J Med; 2009 Aug; 361(7):653-63. PubMed ID: 19675329
[TBL] [Abstract][Full Text] [Related]
2. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells.
Pepels MJ; de Boer M; Bult P; van Dijck JA; van Deurzen CH; Menke-Pluymers MB; van Diest PJ; Borm GF; Tjan-Heijnen VC
Ann Surg; 2012 Jan; 255(1):116-21. PubMed ID: 22183034
[TBL] [Abstract][Full Text] [Related]
3. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
4. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
[TBL] [Abstract][Full Text] [Related]
5. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
6. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
7. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.
Hetterich M; Gerken M; Ortmann O; Inwald EC; Klinkhammer-Schalke M; Eggemann H; Ignatov A
Breast Cancer Res Treat; 2021 Jun; 187(3):715-727. PubMed ID: 33721148
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
11. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of micrometastases and isolated tumor cells in the sentinel node at early stage breast cancer].
Cordero García JM; Palomar Muñoz A; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón A
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):78-82. PubMed ID: 21658817
[TBL] [Abstract][Full Text] [Related]
13. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study.
Maaskant-Braat AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Roumen RM; Nolthenius-Puylaert MC; Nieuwenhuijzen GA
Breast Cancer Res Treat; 2011 May; 127(1):195-203. PubMed ID: 20680679
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study.
Tvedskov TF; Jensen MB; Ejlertsen B; Christiansen P; Balslev E; Kroman N
Breast Cancer Res Treat; 2015 Oct; 153(3):599-606. PubMed ID: 26341752
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients.
Tjan-Heijnen VC; Pepels MJ; de Boer M
Breast Dis; 2010; 31(2):107-13. PubMed ID: 21368373
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
[TBL] [Abstract][Full Text] [Related]
20. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
